Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Dose Adjustments When Using Amprenavir

September 1999

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Amprenavir (Agenerase®), the most recently approved protease inhibitor, is often used by people who have lost responsiveness to one or more of the previously available drugs of this class. It is considered wise in this situation to try to start two new drugs at the same time so many people combine amprenavir with efavirenz (Sustiva®). Unfortunately, few people seem aware that there are significant interactions between these two drugs which require adjusting their dosage.

Efavirenz decreases amprenavir levels in the blood by about 40%, making an increased dose of amprenavir necessary. The optimum dose of amprenavir in this combination is still not clearly established, but some researchers believe it should be increased to 1,200mg three times a day (compared to the standard dose of 1,200mg twice daily). However, early study results indicate that this change in dose is unnecessary if the combination also includes 100-200mg of ritonavir or 1,250mg of nelfinavir taken twice a day along with the amprenavir and efavirenz. Check the chart below for preliminary dosing recommendations.

Drug Combinations

Advertisement
Possible Dose Adjustments

APV 1,200mg, 2x (normal dose).
APV + EFV APV 1,200mg, 3x; EFV 600mg 1x.
APV + EFV + RTV APV 1,200mg, 2x; EFV 600mg 1x; RTV 100-200mg, 2x.
APV + EFV + NFV APV 1,200mg, 2x; EFV 600mg 1x; NFV 1,250mg, 2x.

APV=amprenavir; EFV=efavirenz; RTV=ritonavir; NFV=nelfinavir.


Back to the Project Inform Perspective September 1999 contents page.

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Project Inform. It is a part of the publication Project Inform Perspective. Visit Project Inform's website to find out more about their activities, publications and services.
 
See Also
More on HIV Medications
More News on Amprenavir (Agenerase)

Tools
 

Advertisement